New cloud capabilities cut time to create Tables, Figures, and Listings by 50%
"The introduction of TFL Studio marks a pivotal moment in our mission to bring advanced, cloud-native solutions to drug discovery and development," said William F. Feehery, Chief Executive Officer.
"TFL Studio empowers scientists to create high-quality TFLs up to 50% faster, freeing them from the technical complexities of moving source data, coding, and manual formatting,” said Martin Snyder, President, Certara Data Sciences. “This allows them to focus on science, derive insights more quickly, and ultimately accelerate critical decision-making."
Certara(サターラ)について
サターラは、モデリング&シミュレーション・ソフトウェアと技術を用いて、従来の創薬・開発を変革し、医薬品をよりスピーディーに患者さんに届けることをミッションとしています。製薬、教育機関、規制当局のお客様 2,400人以上、70ヵ国にてサターラの技術やサービスが活用されています。Learn more at certara.com
サターラの問い合わせ先:
Sheila Rocchio
[email protected]
報道機関の皆様:
赤津笑美 (emi.akatsu@certara.com)
[email protected]
先行公開:TFL Studioのお披露目
Get your preview of the upcoming TFL Studio in Phoenix Cloud. Learn how this innovative tool will streamline creating and managing Tables, Figures, and Listings, providing faster results, enhanced flexibility, and streamlined collaboration.



